Brexit

Sanofi ready for a Brexit 'no deal' scenario

18 th February 2019

Sanofi, explains how the company will manage the access to the vaccines and medicines they produce after Brexit.

In a  LinkedIn post, Hugo Fry, Managing Director UK of Sanofi, explains how the company will organise to manage the access to the vaccines and medicines they produce after Brexit.

 

 

More news

At the Chamber
8 May 2019

London Luxury Think Tank 2019

The French Chamber of Great Britain and Walpole, in partnership with Spring Studios, are delighted to launch the second edition of their London Luxury...